NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”)
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Carvana Co. (“Carvana” or the “Company”) (NYSE:
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Coinbase Global, Inc. (“Coinbase” or
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Opendoor Technologies, Inc. (“Opendoor” or the “Company”)
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Uber Technologies, Inc. (“Uber” or
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against NIO, Inc. (“NIO” or the
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Uber Technologies, Inc. (“Uber” or
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (“Enochian” or
Numerous life sciences companies are now deliver Medication and treatment through home kits for patients with mental illness. DrAnsay.coma Germany-based company focused on developing “firsts
Former US President Donald Trump, three of his children and the Trump Organization are the targets of a broad lawsuit filed by the New York
BALA CYNWYD, Pa., Sept. 21, 2022 (GLOBE NEWSWIRE) — The law firm of Brodsky & Smith announces that it is investigating potential claims against the
LOS ANGELES, Sept. 21, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 31, 2022 Deadline for
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”)
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Carvana Co. (“Carvana” or the “Company”) (NYSE:
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Coinbase Global, Inc. (“Coinbase” or
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Opendoor Technologies, Inc. (“Opendoor” or the “Company”)
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Uber Technologies, Inc. (“Uber” or
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against NIO, Inc. (“NIO” or the
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Uber Technologies, Inc. (“Uber” or
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (“Enochian” or
Numerous life sciences companies are now deliver Medication and treatment through home kits for patients with mental illness. DrAnsay.coma Germany-based company focused on developing “firsts
Former US President Donald Trump, three of his children and the Trump Organization are the targets of a broad lawsuit filed by the New York
BALA CYNWYD, Pa., Sept. 21, 2022 (GLOBE NEWSWIRE) — The law firm of Brodsky & Smith announces that it is investigating potential claims against the
LOS ANGELES, Sept. 21, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 31, 2022 Deadline for
